Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Low Chondroitin Levels Due To Poor Quality Control, Cost - ConsumerLab.com

This article was originally published in The Tan Sheet

Executive Summary

Poor quality control and the high cost of chondroitin are likely to blame for below-label levels of the dietary supplement ingredient found in eight of 25 products examined by ConsumerLab.com, the company reported.

You may also be interested in...



Most Glucosamine/Chondroitin Supplements Pass Content, Dosage Tests – CR

Glucosamine/chondroitin supplement consumers should seek the least expensive combination products that contain at least 90% of the labeled amount of the ingredients, Consumer Reports advises in its upcoming January issue

Most Glucosamine/Chondroitin Supplements Pass Content, Dosage Tests – CR

Glucosamine/chondroitin supplement consumers should seek the least expensive combination products that contain at least 90% of the labeled amount of the ingredients, Consumer Reports advises in its upcoming January issue

Most Glucosamine/Chondroitin Supplements Pass Content, Dosage Tests – CR

Glucosamine/chondroitin supplement consumers should seek the least expensive combination products that contain at least 90% of the labeled amount of the ingredients, Consumer Reports advises in its upcoming January issue

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS090961

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel